We can accomplish our mission with Seegene technologies

Seegene aims to bring a healthy life for everyone by creating a new diagnostics paradigm

MDx technology
Wide range of solutions applicable in diverse markets from clinical diagnostics to basic science research
IT convergence technology
Rapid development of innovative diagnostic products and automated software using IT technology based on extensive expertise in developing diagnostic reagents
Automated instrumentation
Deliver clinically useful results fast and accurately for both patients and clinicians with an automated platform
Test platform solution
Develops an optimized MDx platform that enables to provide MDx services at affordable price in any size of hospitals

Seegene’s high multiplex real-time PCR technologies

DPO™ Technology
for multiple target amplification
TOCE™ Technology
for multiple target detection
MuDT™ Technology
for multiple target real-time analysis

Simultaneous detection
Early diagnosis of multiple infections (co-infections by more than one causal pathogen), allowing appropriatetreatment to be applied for each causal pathogen.
Precise diagnosis
Confirm certainty of infection as well as measure severity based on quantitative information of infection, supporting healthcare providers in tracking/responding to patient’s condition.
Timely diagnosis
Detect multiple causal pathogens in a single test, allowing appropriate treatment regimens in the early stage.
Affordable diagnosis
Cost-effective tests not only improve patient management but also relieve financial burden of healthcare system.

High multiplex MDx products

Seegene has produced and delivered molecular diagnostics (MDx) products capable of detecting multiple targets simultaneously.

Seegene’s high multiplex assays deliver comprehensive clinical information in a single test and allow accurate and rapid diagnosis.

Seegene Inc. Videos

Screening and Identification of SARS-CoV-2 & Variants- Video

Euronews_ Seegene (en) - Video